R Francese, M Rittà, D Lembo, M Donalisio - Lupus, 2024 - journals.sagepub.com
After the end of the COVID-19 public health emergency, we analysed the relationship between Systemic Lupus Erythematosous (SLE) and COVID-19 from the virologist's …
SO Kohn, I Jagadish… - Rheumatic Disease …, 2025 - rheumatic.theclinics.com
In March of 2020, the World Health Organization declared the coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
Background Target trial emulation (TTE) has gained popularity in evaluating treatments and health interventions. Its application to infectious disease outcomes requires careful …
J Widdifield, JJY Lee, S Bernatsky - The Lancet Rheumatology, 2024 - thelancet.com
Throughout 2023, SARS-CoV-2 infections continue to be a leading cause of hospitalisations. 1 Ongoing surveillance of the effectiveness of vaccination strategies is a …
The long-term association between mRNA-based Coronavirus Disease 2019 (COVID-19) vaccination and the development of autoimmune connective tissue diseases (AI-CTDs) …
As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) evolves, infection management in vulnerable populations requires formalized guidance. Although low …
J Jin - Molecular simulation, 2008 - ngdc.cncb.ac.cn
BACKGROUND: Balloon pulmonary angioplasty (BPA) has been demonstrated to improve cardiac function and exercise capacity in patients with inoperable chronic thromboembolic …